1. Home
  2. WHG vs TNYA Comparison

WHG vs TNYA Comparison

Compare WHG & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westwood Holdings Group Inc

WHG

Westwood Holdings Group Inc

HOLD

Current Price

$17.99

Market Cap

156.2M

Sector

Finance

ML Signal

HOLD

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.71

Market Cap

171.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHG
TNYA
Founded
1983
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
156.2M
171.4M
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
WHG
TNYA
Price
$17.99
$0.71
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.33
AVG Volume (30 Days)
15.0K
3.0M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
3.58%
N/A
EPS Growth
203.85
54.96
EPS
0.09
N/A
Revenue
$97,762,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$201.33
N/A
Revenue Growth
3.21
N/A
52 Week Low
$14.70
$0.53
52 Week High
$18.99
$2.35

Technical Indicators

Market Signals
Indicator
WHG
TNYA
Relative Strength Index (RSI) 67.40 43.29
Support Level $15.72 $0.65
Resistance Level $18.64 $0.82
Average True Range (ATR) 0.71 0.06
MACD 0.14 -0.01
Stochastic Oscillator 81.43 12.98

Price Performance

Historical Comparison
WHG
TNYA

About WHG Westwood Holdings Group Inc

Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its Advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States, and also has its presence in Canada.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: